Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc. (USPH)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2009
Business Overview: The Company operates outpatient physical and occupational therapy clinics providing pre- and post-operative care, sports injury treatment, and rehabilitation. As of December 31, 2009, USPH operated 368 clinics in 43 states. The business model primarily utilizes "Clinic Partnerships" where the Company holds a majority interest (typically 64%) and managing therapists hold the remainder, alongside wholly-owned facilities. The Company also manages 13 third-party practices.
Key Financial Metrics
| Metric | 2009 | 2008 | Change |
|---|---|---|---|
| Net Revenues | $201.4 million | $187.7 million | +7.3% |
| Net Income (Common Shareholders) | $11.8 million | $10.0 million | +17.6% |
| Diluted EPS | $1.00 | $0.83 | +20.5% |
| Operating Income | $28.3 million | $23.9 million | +18.3% |
| Cash and Cash Equivalents | $6.4 million | $10.1 million | -36.6% |
| Working Capital | $18.3 million | $24.1 million | -24.1% |
| Long-Term Debt | $0.4 million | $12.4 million | -96.8% |
| Current Ratio | 2.24 | 2.65 | -15.5% |
Operational Metrics: Total patient visits increased 1.8% to 1.9 million. Net patient revenue per visit rose 4.9% to $102.85. The Company opened 18 new clinics and closed 10 during the year.
Material Changes vs. Prior Period
- Revenue Growth: Driven by a 4.9% increase in revenue per visit and a 1.8% increase in total visits. The 2009 results include a full year of operations for clinics acquired in 2008 (Mid-Atlantic and San Antonio acquisitions).
- Profitability: Net income attributable to common shareholders increased significantly due to higher operating income and a reduction in interest expense ($352k in 2009 vs. $542k in 2008) resulting from lower debt levels.
- Debt Reduction: The Company aggressively paid down its revolving credit facility, reducing the outstanding balance from $11.4 million in 2008 to $0.4 million in 2009.
- Cash Flow: Cash and cash equivalents decreased by $3.7 million. This was primarily due to investing and financing activities, including $12.4 million in debt repayments, $9.4 million in distributions to noncontrolling interests, and $5.6 million in stock repurchases, partially offset by $30.9 million in operating cash flow.
- Accounting Change: The Company adopted new FASB guidance regarding noncontrolling interests effective January 1, 2009, requiring net income attributable to noncontrolling interests to be included in consolidated net income on the face of the income statement.
Guidance, Outlook, and Risks
Outlook and Strategy: Management intends to continue developing new clinics and opening satellite locations in 2010. The Company plans to evaluate acquisition opportunities and increase patient volume through marketing. No specific numerical guidance for 2010 revenue or earnings was provided in the text.
Key Risks and Contingencies:
- Reimbursement Environment: Approximately 80% of revenue comes from third-party payors (managed care, commercial insurance, workers' comp). The Company faces risks from cost-containment initiatives and potential rate reductions.
- Medicare Cap: Services are subject to the Medicare therapy cap. While exceptions exist, the cap may result in lost revenue. The Company is in the process of submitting claims for services furnished in early 2010 that exceeded the cap under previous laws.
- Economic Conditions: High unemployment and reduced discretionary spending could lead to a decline in patient visits or difficulty in collecting receivables.
- Regulatory Compliance: The business is subject to extensive federal and state regulations, including the Fraud and Abuse Law, Stark Law, and HIPAA. Non-compliance could result in penalties or exclusion from government programs.
- Goodwill Impairment: The Company holds significant goodwill ($57.2 million). Future deterioration in market conditions or clinic performance could trigger impairment charges.
Investor Verification Checklist
- Debt Covenants: Verify continued compliance with the $50 million revolving credit facility covenants, specifically the consolidated leverage ratio requirement (must be less than 1.0 to 1.0) which was amended to permit stock repurchases.
- Medicare Cap Exceptions: Monitor the successful submission and reimbursement of claims held for patients exceeding the Medicare cap in early 2010.
- Stock Repurchase Program: Confirm the status of the March 2009 authorization to repurchase up to 1.2 million shares; the Company spent $5.6 million on 518,335 shares in 2009.
- Acquisition Integration: Assess the performance of the 2008 acquisitions (Mid-Atlantic, San Antonio, RMG) which contributed significantly to 2009 revenue growth.
- Noncontrolling Interest Distributions: Review cash flow impacts from distributions to noncontrolling interest partners, which totaled $9.4 million in 2009.